Basic Information
| LncRNA/CircRNA Name | lnc-SLC4A1-1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Western blot, RIP |
| Sample | BC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | Lnc-SLC4A1-1 was significantly up-regulated in BC tissue, serum samples and cell lines. |
| Pubmed ID | 31556319 |
| Year | 2019 |
| Title | Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. |
External Links
| Links for lnc-SLC4A1-1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |